Who owns Bolt Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BOLT from SEC Form 13F filings across 23 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 23 institutions disclosed 576,383 shares of Bolt Biotherapeutics, Inc. worth $2.1M — about 29.3% of shares outstanding; the largest disclosed holder is Sofinnova Investments, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
23
13F holders
$2.1M
value, 2026 filers
29.3%
of shares outstanding (576,383 sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BOLT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Sofinnova Investments, Inc. | 137,721 | $506,813 | 0.0% | 7% | 0.0% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 92,925 | $341,964 | 0.0% | 4.7% | -5.8% |
| 3 | Vivo Capital, LLC | 72,414 | $266,484 | 0.0% | 3.7% | 0.0% |
| 4 | T3 Companies, LLC | 38,000 | $139,840 | 0.1% | 1.9% | 0.0% |
| 5 | Board of Trustees of The Leland Stanford Junior University | 35,977 | $132,395 | 0.0% | 1.8% | 0.0% |
| 6 | Pfizer Inc | 31,305 | $112,072 | 0.1% | 1.6% | 0.0% |
| 7 | Lynx1 Capital Management LP | 30,800 | $113,344 | 0.0% | 1.6% | 0.0% |
| 8 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 27,500 | $101,200 | 0.1% | 1.4% | 0.0% |
| 9 | CITADEL ADVISORS LLC | 18,300 | $67,344 | 0.0% | 0.9% | -67.8% |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 16,838 | $61,964 | 0.0% | 0.9% | new |
| 11 | Shay Capital LLC | 16,526 | $60,816 | 0.0% | 0.8% | +7.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 15,797 | $58,146 | 0.0% | 0.8% | -17.4% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 15,533 | $57,161 | 0.0% | 0.8% | +401.9% |
| 14 | BlackRock, Inc. | 9,711 | $35,737 | 0.0% | 0.5% | 0.0% |
| 15 | VANGUARD CAPITAL MANAGEMENT LLC | 7,060 | $25,981 | 0.0% | 0.4% | 0.0% |
| 16 | Nan Fung Group Holdings Ltd | 5,000 | $18,400 | 0.0% | 0.3% | 0.0% |
| 17 | MORGAN STANLEY | 4,167 | $15,335 | 0.0% | 0.2% | +32.5% |
| 18 | Tower Research Capital LLC (TRC) | 500 | $1,840 | 0.0% | 0% | -70.8% |
| 19 | JPMORGAN CHASE & CO | 290 | $1,058 | 0.0% | 0% | +590.5% |
| 20 | SBI Securities Co., Ltd. | 10 | $37 | 0.0% | 0% | -92.3% |
| 21 | BARCLAYS PLC | 6 | $22 | 0.0% | 0% | 0.0% |
| 22 | UBS Group AG | 2 | $7 | 0.0% | 0% | -99.2% |
| 23 | CITIGROUP INC | 1 | $4 | 0.0% | 0% | -97.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.